SNTI
Income statement / Annual
Last year (2023), Senti Biosciences, Inc.'s total revenue was $2.56 M,
a decrease of 40.25% from the previous year.
In 2023, Senti Biosciences, Inc.'s net income was -$71.06 M.
See Senti Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$2.56 M
|
$4.29 M
|
$2.29 M
|
$394,000.00
|
$85,000.00
|
| Cost of Revenue |
$5.24 M |
$3.92 M |
$3.01 M |
$15.96 M |
$14.52 M |
| Gross Profit |
-$2.68 M |
$366,000.00 |
-$719,000.00 |
-$15.56 M |
-$14.44 M |
| Gross Profit Ratio |
-1.05 |
0.09 |
-0.31 |
-39.5 |
-169.87 |
| Research and Development
Expenses |
$31.08 M
|
$34.07 M
|
$21.96 M
|
$15.96 M
|
$14.52 M
|
| General & Administrative
Expenses |
$34.87 M
|
$40.85 M
|
$21.25 M
|
$9.30 M
|
$7.34 M
|
| Selling & Marketing
Expenses |
-$4.18 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$33.00 M
|
$40.85 M
|
$21.25 M
|
$9.30 M
|
$7.34 M
|
| Other Expenses |
$2.29 M |
$12.42 M |
-$470,000.00 |
-$172,000.00 |
$0.00 |
| Operating Expenses |
$64.08 M |
$74.92 M |
$42.74 M |
$25.09 M |
$7.39 M |
| Cost And Expenses |
$69.33 M |
$74.92 M |
$42.74 M |
$25.09 M |
$21.92 M |
| Interest Income |
$2.86 M |
$1.70 M |
$11,000.00 |
$88,000.00 |
$674,000.00 |
| Interest Expense |
$0.00 |
-$3.92 M |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$5.24 M
|
$3.89 M
|
$3.01 M
|
$1.99 M
|
$427,000.00
|
| EBITDA |
-$61.52 M
|
-$70.63 M
|
-$37.41 M
|
-$22.47 M
|
-$21.36 M
|
| EBITDA Ratio |
-24.02 |
-16.48 |
-16.33 |
-57.03 |
-251.24 |
| Operating Income Ratio
|
-26.07
|
-16.48
|
-17.65
|
-62.68
|
-256.26
|
| Total Other
Income/Expenses Net |
-$16.64 M
|
$12.42 M
|
-$14.87 M
|
$4.83 M
|
$625,000.00
|
| Income Before Tax |
-$83.41 M |
-$58.21 M |
-$55.32 M |
-$19.86 M |
-$21.16 M |
| Income Before Tax Ratio
|
-32.57
|
-13.58
|
-24.15
|
-50.41
|
-248.91
|
| Income Tax Expense |
$9.51 M |
-$12.42 M |
$11,000.00 |
$150,000.00 |
$0.00 |
| Net Income |
-$71.06 M |
-$58.21 M |
-$55.32 M |
-$19.86 M |
-$21.16 M |
| Net Income Ratio |
-27.75 |
-13.58 |
-24.15 |
-50.41 |
-248.91 |
| EPS |
-16.01 |
-22.29 |
-12.67 |
-4.55 |
-1.56 |
| EPS Diluted |
-16.01 |
-22.29 |
-12.67 |
-4.55 |
-1.56 |
| Weighted Average Shares
Out |
$4.44 M
|
$2.61 M
|
$4.37 M
|
$4.37 M
|
$13.59 M
|
| Weighted Average Shares
Out Diluted |
$4.44 M
|
$2.61 M
|
$4.37 M
|
$4.37 M
|
$13.59 M
|
| Link |
|
|
|
|
|
